Search

Start typing to see results...

  • Home
  • >
  • Stock Market
  • >
  • Mankind Pharma Ltd

Mankind Pharma Ltd share price and stock overview

Mankind Pharma Ltd (NSE: MANKIND, BSE: 543904) operates in the Pharmaceuticals - Indian - Bulk Drugs & Formln sector. The stock has an ISIN of INE634S01028 and a face value of Rs 1. As of 12 September 2026, it trades at Rs (2,280.00) with a market capitalisation of Rs 92769.93 crore. Figures are live and subject to change.

Mankind Pharma Ltd

Pharmaceuticals - Indian - Bulk Drugs & Formln
NSE BSE
2,280.00 41.60 (1.86%) upARrowC
As on: 12-Sep-2026 , 04:13 AM
Market Cap(₹Cr) 92769.93
Book Value(₹Cr) 396.9775917
BSE Code : 543904 NSE Symbol : MANKIND EPS(TTM) : 54.75 ISIN Demat : INE634S01028 P/E(TTM) : 41.02 Face Value(₹) : 1 Div & Yield % : 0.04

Today Market

Stock Performance

Today Market

Today's High

74,917.15

Todday's Low

74,160.16

Open at

74,309.16

Previous Close

74,902.59

Volumes

Avg Price

-120.83

Historical Performance

News

09 Sep 26
Mankind Pharma Ltd slips for fifth straight session
Mankind Pharma Ltd is down for a fifth straight session today. The stock is quoting at Rs 2280.
01 Sep 26
Mankind Pharma allotted equity shares to employees under its 2022 stock option plan
Mankind Pharma Limited announced the allotment of 49,112 equity shares to eligible employees under its Mankind Employee Stock Option Plan 2022, according to a regulatory filing on September 1, 2026.
30 Aug 26
Mankind Pharma confirms Bharat Anand's departure as Independent Director, committee resignations effective August 30, 2026
Mankind Pharma Limited informed the BSE Limited and National Stock Exchange of India that Bharat Anand has ceased to be an Independent Director with effect from August 30, 2026, following the completion of his second term, and has also resigned from the Audit Committee, Nomination and Remuneration Committee, Risk Management Committee, and Corporate Social Responsibility Committee.
26 Aug 26
Mankind Pharma’s board approved liquidation of Bharat Serums and Vaccines subsidiary
Mankind Pharma Limited announced that its board approved the voluntary liquidation of its 96% owned subsidiary, Bharat Serums and Vaccines Limited (BSVL), with Appian Properties Private Limited, a wholly owned subsidiary of Mankind Pharma, holding the remaining 4% stake.

Historical Prices

Share Price Chart

Historical Share Price

From Date:
To Date:     
Date Open Price (₹) High Price(₹) Low Price(₹) Close Price(₹) Total Volume No of Trades Net Turnover(₹) NIFTY
11-09-26 2237.20 2280.00 2222.00 2280.00 530698 18199 1196849321.50 23398.10
10-09-26 2260.00 2276.50 2235.10 2238.40 180515 15860 407656592.90 23477.80
09-09-26 2305.00 2317.60 2250.00 2265.00 266219 18670 607349764.30 23431.50
08-09-26 2318.00 2330.80 2301.00 2309.00 186335 18108 430348005.70 23635.10
07-09-26 2317.00 2331.60 2303.50 2318.00 153500 15386 355542319.80 23779.15
04-09-26 2366.50 2390.00 2317.00 2327.90 122389 12835 286487165.10 23897.70
03-09-26 2390.00 2390.00 2355.40 2368.80 98805 10116 233820855.10 23873.45
02-09-26 2351.00 2391.50 2341.20 2391.50 334009 26083 792952516.80 23914.45
01-09-26 2381.40 2381.40 2350.00 2356.50 282979 22548 667067767.60 24055.80
31-08-26 2407.60 2419.20 2343.60 2419.20 391957 16968 934169693.10 24080.40
123...

Fundamentals

Company Valuation

Market Cap (₹cr)

92769.93

PE Ratio

41.02

PB Ratio

5.66

Dividend Yield

0.04

ROE

13.27

ROCE

13.07

Book Value (₹)

396.9775917

Face Value (₹)

1

Share Holding Pattern

Category of Shareholder No of Shares % Share Holdings Demat Shares Share Holders
plus  Promoter & Group
plus  Foreign
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
plus  Indian
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 74921805 18.14 74921805 10
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 225038807 54.49 225038807 3
Others 0 0.00 0 0
Sub Total 299960612 72.63 299960612 13
Total ShareHolding for Promoter & Group 299960612 72.63 299960612 13
plus   Publice Share Holding
plus  Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 8400 0.00 8400 2
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 39041918 9.45 39041918 501
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 6358592 1.54 6358592 17
Mutual Funds / UTI 44889663 10.87 44889663 36
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 12299126 2.98 12299126 25
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 102597699 24.84 102597699 581
plus  Non Institution
Bodies Corporate 4287989 1.04 4287989 598
Clearing Members 199392 0.05 199392 3
Directors & their Relatives 0 0.00 0 0
Employees 196682 0.05 196682 14
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 213336 0.05 213336 2832
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 187319 0.05 187319 3198
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 0 0.00 0 0
Individuals holding nominal share capital up to Rs. 1 lakh 5321321 1.29 5321321 159467
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 4715 0.00 4715 8
Others 26913 0.01 26913 1
Sub Total 10437667 2.53 10437667 166121
Total Public Shareholding 113035366 27.37 113035366 166702
Total of Promoter & Public ShareHolding 412995978 100.00 412995978 166715
plus  Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total 412995978 100.00 412995978 166715

Financials (₹ in cr)

Consolidated Standalone
Year EndMar 2026Mar 2025Mar 2024Mar 2023Mar 2022
Net Sales14,277.6412,207.4410,260.448,749.437,781.56
OPM (%)17.2520.6123.3719.1025.38
OP2,462.432,516.332,397.941,671.241,974.60
Other Income358.79536.79280.22128.57196.03
PBIDT3,858.143,566.962,809.112,041.632,199.83
INTEREST639.28429.4132.7544.4758.61
PBDT3,218.863,137.552,776.361,997.162,141.22
PBT2,202.932,516.332,397.941,671.241,974.60
EO-129.750.000.000.000.00
PBT after EO2,332.682,516.332,397.941,671.241,974.60
TAXES394.58509.74457.15361.56521.64
PAT1,912.931,990.961,912.901,281.861,433.48
EPS46.2849.1947.6832.0035.78
Raw Material16.0316.5217.9620.7326.44
Power and Fuel1.291.221.221.251.33
Employee Cost22.3022.0622.0321.9320.83
Other Manufacturing Expenses0.000.000.000.000.00
Selling and Administration Expenses19.4519.9818.2318.4818.12
Miscellaneous Expenses1.081.341.231.741.57
Revenue (Growth %) 16.9618.9817.2712.4425.22
PBIDT (Growth %)8.1626.9837.59-7.1920.16
PAT (Growth %) -3.924.0849.23-10.5813.28
PBIDT (Margin %)27.0229.2227.3823.3328.27
PAT (Margin %) 13.4016.3118.6414.6518.42

Balance Sheet (₹ in cr)

Particulars (Sources Of Funds)Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021
Share Capital 41.2841.2640.0640.0640.0640.06
Reserves Total 16355.6614281.469662.717743.856500.394694.21
Equity Share Warrants0.000.000.000.000.000.00
Equity Application Money0.000.000.000.000.000.00
Total Shareholders Funds16396.9414322.729702.777783.916540.454734.27
Secured Loans 5488.265444.2714.930.00623.6695.00
Unsecured Loans 82.521938.788.574.6964.235.85
Total Debt5570.787383.0523.504.69687.89100.85
Other Liabilities225.97131.37124.73109.0489.0262.92
Total Liabilities22193.6921837.149851.007897.647317.364898.04
APPLICATION OF FUNDS :
Gross Block 5891.355658.484578.233775.593292.311227.09
Less : Accumulated Depreciation 1965.541582.511026.67633.37365.62239.68
Less:Impairment of Assets0.000.000.000.000.000.00
Net Block 3925.814075.973551.563142.222926.69987.41
Lease Adjustment0.000.000.000.000.000.00
Capital Work in Progress420.04207.43209.44494.78386.57165.57
Producing Properties0.000.000.000.000.000.00
Investments 16523.1516683.384215.363102.232525.872396.89
Current Assets, Loans & Advances
Inventories 1087.841097.941126.031032.221266.69826.91
Sundry Debtors 1163.63908.71769.04492.64470.59369.17
Cash and Bank Balance159.22306.26483.88155.15138.85476.95
Loans and Advances 724.00848.931011.09775.441070.80520.92
Total Current Assets3134.693161.843390.042455.452946.922193.95
Less : Current Liabilities and Provisions
Current Liabilities 1726.662036.401179.711080.011319.07789.20
Provisions 704.96567.37419.30337.61266.74193.08
Total Current Liabilities & Provisions2431.622603.771599.011417.621585.81982.28
Net Current Assets703.07558.071791.031037.831361.111211.66
Miscellaneous Expenses not written off 0.000.000.000.000.000.00
Deferred Tax Assets464.76398.21358.15263.37165.26122.49
Deferred Tax Liability291.30415.53424.53319.23200.79109.45
Net Deferred Tax173.46-17.32-66.38-55.86-35.5313.04
Other Assets448.16329.61149.99176.45152.67123.47
Total Assets22193.6921837.149851.007897.657317.374898.04
Contingent Liabilities1123.831193.31247.0078.72135.2415.79

Cash Flow (₹ in cr)

Yearly Cash FlowMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Financing Activities 578.63-710.41-4.739,816.50-2,476.92
Investing Activities -1,360.27-1,040.61-1,665.19-12,177.60-388.09
Net Cash Flow 39.8147.9666.16-10.96-113.02
Operating Activities 821.441,798.991,736.082,350.142,751.99

Corporate Actions

Bonus Dividends Splits
DateCorporate ActionInformation
No Corporate Actions Announced

Board of Directors

Chairman & Chief Executive Officer
RCJ
RAMESH CHAND JUNEJA
Chairman/ED & CEO
Executive
RJ
RAJEEV JUNEJA
Vice Chairman & M.D.
Executive
Functional Directors
SKS
SATISH KUMAR SHARMA
E D & Wholetime Director
Dir.
Independent Directors
TPO
TILOKCHAND PUNAMCHAND OSTWAL
Independent Non Exe. Director
Ind.
VS
VIJAYA SAMPATH
Independent Non Exe. Director
Ind.
VK
Vivek Kalra
Independent Non Exe. Director
Ind.
Other Officials
SA
SHEETAL ARORA
ED / WTD / CEO / Promoter
Board
HKJ
Hitesh Kumar Jain
Company Sec. & Compli. Officer
Board

Frequently Asked Questions

What is the NSE symbol and BSE code for Mankind Pharma Ltd? −

Mankind Pharma Ltd trades on NSE under MANKIND and on BSE under code 543904. The ISIN is INE634S01028 and the face value is Rs 1.

What is the share price of Mankind Pharma Ltd today? +

As of 12 September 2026, Mankind Pharma Ltd trades at Rs 2,280.00, a change of 41.60 (1.86%) on the day. Prices are live and subject to change.

What is the market capitalisation of Mankind Pharma Ltd? +

As of 12 September 2026, Mankind Pharma Ltd has a market cap of about Rs 92769.93 crore. This figure is live and moves with the share price.

Is Mankind Pharma Ltd profitable? +

In March 2026, Mankind Pharma Ltd reported a profit after tax of Rs 1,912.93 crore. The wording switches to "a net loss of Rs X crore" when the figure is negative.

What is the PE ratio of Mankind Pharma Ltd? +

: As of 12 September 2026, the PE (TTM) for Mankind Pharma Ltd is 41.02 and the price-to-book ratio is 5.66. When the PE shows zero, state that PE TTM is currently not applicable and give the PB only.

Does Mankind Pharma Ltd pay a dividend? +

As of 12 September 2026, the dividend yield for Mankind Pharma Ltd is 0.04%. The wording switches to "does not currently pay a dividend" when the yield is zero.

What is the shareholding pattern of Mankind Pharma Ltd? +

As of the latest disclosed pattern, promoters hold 72.63% of Mankind Pharma Ltd. Public shareholding is 27.37%, including mutual funds at 10.87% and foreign institutional investors at 9.45%.

What were the latest annual financials of Mankind Pharma Ltd? +

In March 2026, Mankind Pharma Ltd reported net sales of Rs 14,277.64 crore, revenue growth of 16.96%, and earnings per share of Rs 46.28.